At a glance
- Japanese name
- 小林製薬株式会社
- Established
- 1886
- Location
- Chuo, Osaka
- English support
- English corporate site; international division
- Export experience
- Asia, US
- Certifications
- ISO 9001, GMP (pharmaceutical)
- Website
- www.kobayashi.co.jp/english
Editor's scoring
Overall 12/25 (48%)
- English supportLimited
- Export experienceAdequate
- Certification breadthAdequate
- MOQ flexibilityLimited
- Lead timeLimited
Editorial scores are derived from public evidence and our editorial assessment. Not a paid placement. Read the scoring methodology →
About
Tokyo-listed OTC pharmaceutical and consumer-health group founded 1886. Best-known internationally for Eyebon eye-care, Netsusama-Sheet, and the Kuwa-no-Ha (mulberry leaf) functional-food line. The Kobayashi B2B ingredient channel supplies a portfolio of Japanese-botanical functional ingredients (mulberry leaf, gymnema, momordica, etc.) to overseas supplement OEMs. Strict quality controls on Kampo-derived materials make Kobayashi a frequent reference supplier for compliance-sensitive overseas buyers.
Ingredients offered
FAQ about Kobayashi Pharmaceutical Co., Ltd.
Q. What does Kobayashi Pharmaceutical Co., Ltd. produce?
Kobayashi Pharmaceutical Co., Ltd. is listed on this platform with 1 ingredient for overseas B2B sourcing. Their listed categories include medicinal plants. Examples include Yamabushitake (Lion's Mane Mushroom).
Sources
- OEM JAPAN — sourcing platform manufacturer record
- Kobayashi Pharmaceutical Co., Ltd. official site
Q. Where is Kobayashi Pharmaceutical Co., Ltd. located, and how does that affect shipping?
Kobayashi Pharmaceutical Co., Ltd. is based in Chuo, Osaka, Japan (established 1886). Most Japanese manufacturers ship internationally via Tokyo, Osaka, or Yokohama ports; expect 4–8 weeks typical lead time for production and 2–4 weeks for ocean freight to North America/Europe.
Sources
- OEM JAPAN — sourcing platform manufacturer record
- Industry knowledge — Japanese export logistics
Industry-knowledge claim — not yet pinned to a single primary source
Q. Does Kobayashi Pharmaceutical Co., Ltd. support overseas buyers in English?
Yes. English corporate site; international division Initial inquiries are routed through OEM JAPAN's operator team to ensure clear specification handoff.
Sources
- OEM JAPAN — sourcing platform manufacturer record
Q. What certifications and export experience does Kobayashi Pharmaceutical Co., Ltd. have?
Kobayashi Pharmaceutical Co., Ltd. holds ISO 9001 and GMP (pharmaceutical). They have prior export experience (markets served include: Asia, US).
Sources
- OEM JAPAN — sourcing platform manufacturer record
Q. What's the inquiry process for Kobayashi Pharmaceutical Co., Ltd.?
Submit an inquiry through OEM JAPAN's form on this page describing your target product, target market, MOQ, and timeline. The operator team verifies the inquiry, contacts Kobayashi Pharmaceutical Co., Ltd. on your behalf, and returns with availability, pricing, lead time, and required documentation. There is no direct fee for buyers using this matching service.
Sources
- OEM JAPAN — buyer guide
Disclaimer
Japan Ingredient Sourcing Platform introduces overseas buyers to Japanese ingredient manufacturers. The platform is an information service only and is not a party to any purchase, supply, or manufacturing contract between buyer and seller.
Information shown — including company details, product descriptions, regions of origin, minimum order quantities, lead times, certifications, and regulatory references — is compiled primarily from publicly available sources and manufacturer websites. Specifications change without notice; buyers are expected to verify current specifications, pricing, certification status, and regulatory compliance directly with each manufacturer before placing orders or signing contracts.
The platform operator is not licensed to provide legal, regulatory, customs, tax, or professional advice. References to third-party companies, products, certifications, trademarks, and geographical indications (GI) are factual and do not imply endorsement, sponsorship, or affiliation. All trademarks are the property of their respective owners.
Last updated: 2026-05-05